Christopher Straub

Novartis Institutes for Biomedical Research

Sympathy for the Devil: Taking IAP Antagonists from Research to the Clinic

Peter H. Seeberger

Max-Planck Institute for Colloids and Interfaces

Preventing and Curing Infectious Diseases: Carbohydrate Vaccines and Continuous Flow Synthesis

Charge Transfer and Chemistry at Catalytic Interfaces

Abstract

Title of the Talk: "Who can made the most complicated molecules: Chemists, or Biochemists, or a combination of both?"